Antifibrotics in NON IPF ILD

(1:28:11)

Debate on Antifibrotics in post Covid fibrosis

(1:53:36)

Choosing NOT to take antifibrotic medication

(5:23)

Antifibrotic treatment in Pulmonary Fibrosis

(8:29)

Approaching a New Era in the Management of Progressive Fibrosing ILDs

(45:12)

Which Patients with IPF Should be on Antifibrotics? The Value of Shared Decision Making

(46)

Evolution of Antifibrotic Therapy in IPF

(3:8)

Comment on antifibrotics in DPLD in response to a presentation on it.

(8:25)

IPF Real world long term experience with antifibrotic treatment

(7:14)

Dr. Charlene Fell – Generic Antifibrotics: Is a Rose a Rose by Any Other Name?

(1:24:23)

Medications for pulmonary fibrosis: antifibrotics and immunomodulators

(1:6:52)

Applying the Evidence on Antifibrotic Agents for IPF

(10:44)

S1 Episode 2: Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic?

(24:16)

IPF Management and Antifibrotic Therapy

(56:49)

Expanding the Use of Antifibrotic Therapy in Patients with PF

(5:21)

Current Perspective on Antifibrotic Therapy for Patients with IPF

(2:11)

Exploring Antifibrotic Therapy in Patients with Autoimmune Associated ILD

(3:15)

Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD

(13:9)

Antifibrotics and Progressive Fibrotic ILD

(37:47)

Pulmonary Fibrosis nursing - What does an ILD specialist nurse do?

(9:22)